BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Najafi M, Farhood B, Mortezaee K. Cancer stem cells (CSCs) in cancer progression and therapy. J Cell Physiol 2019;234:8381-95. [DOI: 10.1002/jcp.27740] [Cited by in Crossref: 117] [Cited by in F6Publishing: 183] [Article Influence: 29.3] [Reference Citation Analysis]
Number Citing Articles
1 Fan Y, Gao Z, Xu J, Wang H, Guo Q, Xue H, Zhao R, Guo X, Li G. Identification and validation of SNHG gene signature to predict malignant behaviors and therapeutic responses in glioblastoma. Front Immunol 2022;13:986615. [DOI: 10.3389/fimmu.2022.986615] [Reference Citation Analysis]
2 Shu X, Chen M, Liu S, Yu L, Sun L, Sun L, Ran Y. Palladin promotes cancer stem cell‐like properties in lung cancer by activating Wnt/ Β‐Catenin signaling. Cancer Medicine. [DOI: 10.1002/cam4.5192] [Reference Citation Analysis]
3 Chen X, Liu Y, Tao B, Xue X, Zhang X, Wang L, Zhong H, Zhang J, Yang S, Jiang Q. NT5E upregulation in head and neck squamous cell carcinoma: A novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment. Front Immunol 2022;13:975847. [DOI: 10.3389/fimmu.2022.975847] [Reference Citation Analysis]
4 Han X, Li B. The emerging role of noncoding RNAs in the Hedgehog signaling pathway in cancer. Biomed Pharmacother 2022;154:113581. [PMID: 36037783 DOI: 10.1016/j.biopha.2022.113581] [Reference Citation Analysis]
5 Akindona FA, Frederico SC, Hancock JC, Gilbert MR. Exploring the origin of the cancer stem cell niche and its role in anti-angiogenic treatment for glioblastoma. Front Oncol 2022;12:947634. [DOI: 10.3389/fonc.2022.947634] [Reference Citation Analysis]
6 Guo L, Yan T, Guo W, Niu J, Wang W, Ren T, Huang Y, Xu J, Wang B. Molecular subtypes of osteosarcoma classified by cancer stem cell related genes define immunological cell infiltration and patient survival. Front Immunol 2022;13:986785. [DOI: 10.3389/fimmu.2022.986785] [Reference Citation Analysis]
7 Wang J, Shao F, Yang Y, Wang W, Yang X, Li R, Cheng H, Sun S, Feng X, Gao Y, He J, Lu Z. A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability. Cancer Commun (Lond) 2022. [PMID: 35975322 DOI: 10.1002/cac2.12351] [Reference Citation Analysis]
8 Sher G, Masoodi T, Patil K, Akhtar S, Kuttikrishnan S, Ahmad A, Uddin S. Dysregulated FOXM1 Signaling in the regulation of cancer stem cells. Semin Cancer Biol 2022:S1044-579X(22)00180-8. [PMID: 35931301 DOI: 10.1016/j.semcancer.2022.07.009] [Reference Citation Analysis]
9 Wang H, Wang X, Ye X, Ju Y, Cao N, Wang S, Cai J. Nonviral mcDNA-mediated bispecific CAR T cells kill tumor cells in an experimental mouse model of hepatocellular carcinoma. BMC Cancer 2022;22:814. [PMID: 35879685 DOI: 10.1186/s12885-022-09861-1] [Reference Citation Analysis]
10 Nayak A, Warrier NM, Kumar P. Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems. Stem Cell Rev Rep 2022. [PMID: 35876959 DOI: 10.1007/s12015-022-10426-9] [Reference Citation Analysis]
11 Zhou H, He Q, Li C, Alsharafi BLM, Deng L, Long Z, Gan Y. Focus on the tumor microenvironment: A seedbed for neuroendocrine prostate cancer. Front Cell Dev Biol 2022;10:955669. [DOI: 10.3389/fcell.2022.955669] [Reference Citation Analysis]
12 Hussen BM, Kheder RK, Abdullah ST, Hidayat HJ, Rahman HS, Salihi A, Taheri M, Ghafouri-Fard S. Functional interplay between long non-coding RNAs and Breast CSCs. Cancer Cell Int 2022;22:233. [PMID: 35864503 DOI: 10.1186/s12935-022-02653-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M, Tao Q, Xu H. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol Cancer 2022;21:144. [PMID: 35836256 DOI: 10.1186/s12943-022-01616-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Li J, Peng L, Chen Q, Ye Z, Zhao T, Hou S, Gu J, Hang Q. Integrin β1 in Pancreatic Cancer: Expressions, Functions, and Clinical Implications. Cancers 2022;14:3377. [DOI: 10.3390/cancers14143377] [Reference Citation Analysis]
15 Zaki I, Masoud RE, Hamoud MM, Ali OAA, Abualnaja M, Fayad E, Almaaty AHA, Elnaghia LK. Design, synthesis and cytotoxicity screening of new synthesized pyrimidine-5-carbonitrile derivatives showing marked apoptotic effect. Journal of Molecular Structure 2022;1259:132749. [DOI: 10.1016/j.molstruc.2022.132749] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Kwiatkowska I, Hermanowicz JM, Iwinska Z, Kowalczuk K, Iwanowska J, Pawlak D. Zebrafish—An Optimal Model in Experimental Oncology. Molecules 2022;27:4223. [DOI: 10.3390/molecules27134223] [Reference Citation Analysis]
17 Li L, Gao J, Li J, Wang J. MiR-711 regulates gastric cancer progression by targeting CD44. Cancer Biomark 2022. [PMID: 35786646 DOI: 10.3233/CBM-210213] [Reference Citation Analysis]
18 Zhou Y, Qiu S, Kim JT, Lee SB, Park HJ, Son MJ, Lee HJ, Chen J. Garcinone C Suppresses Tumorsphere Formation and Invasiveness by Hedgehog/Gli1 Signaling in Colorectal Cancer Stem-like Cells. J Agric Food Chem 2022. [PMID: 35749593 DOI: 10.1021/acs.jafc.2c01891] [Reference Citation Analysis]
19 Karnik I, Sutherland R, Elson J, Aspinall S, Meeson A. TGF-β, to target or not to target; to prevent thyroid cancer progression? Biochim Biophys Acta Rev Cancer 2022;1877:188752. [PMID: 35728736 DOI: 10.1016/j.bbcan.2022.188752] [Reference Citation Analysis]
20 Vasefifar P, Motafakkerazad R, Maleki LA, Najafi S, Ghrobaninezhad F, Najafzadeh B, Alemohammad H, Amini M, Baghbanzadeh A, Baradaran B. Nanog, as a key cancer stem cell marker in tumor progression. Gene 2022;827:146448. [PMID: 35337852 DOI: 10.1016/j.gene.2022.146448] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Zheng H, Liu H, Li H, Dou W, Wang J, Zhang J, Liu T, Wu Y, Liu Y, Wang X. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer. Stem Cell Res Ther 2022;13:244. [PMID: 35681225 DOI: 10.1186/s13287-022-02913-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Wei Y, Amend B, Todenhöfer T, Lipke N, Aicher WK, Fend F, Stenzl A, Harland N. Urinary Tract Tumor Organoids Reveal Eminent Differences in Drug Sensitivities When Compared to 2-Dimensional Culture Systems. Int J Mol Sci 2022;23:6305. [PMID: 35682984 DOI: 10.3390/ijms23116305] [Reference Citation Analysis]
23 Ju F, Atyah MM, Horstmann N, Gul S, Vago R, Bruns CJ, Zhao Y, Dong QZ, Ren N. Characteristics of the cancer stem cell niche and therapeutic strategies. Stem Cell Res Ther 2022;13:233. [PMID: 35659296 DOI: 10.1186/s13287-022-02904-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Zhang Y, Liu Y, Lang F, Yang C. IDH mutation and cancer stem cell. Essays Biochem 2022:EBC20220008. [PMID: 35611837 DOI: 10.1042/EBC20220008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Geng R, Harland N, Montes-Mojarro IA, Fend F, Aicher WK, Stenzl A, Amend B. CD24: A Marker for an Extended Expansion Potential of Urothelial Cancer Cell Organoids In Vitro? Int J Mol Sci 2022;23:5453. [PMID: 35628262 DOI: 10.3390/ijms23105453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Sabu A, Liu TI, Ng SS, Doong RA, Huang YF, Chiu HC. Nanomedicines Targeting Glioma Stem Cells. ACS Appl Mater Interfaces 2022. [PMID: 35544684 DOI: 10.1021/acsami.2c03538] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Feliz Morel ÁJ, Hasanovic A, Morin A, Prunier C, Magnone V, Lebrigand K, Aouad A, Cogoluegnes S, Favier J, Pasquier C, Mus-veteau I. Persistent Properties of a Subpopulation of Cancer Cells Overexpressing the Hedgehog Receptor Patched. Pharmaceutics 2022;14:988. [DOI: 10.3390/pharmaceutics14050988] [Reference Citation Analysis]
28 Di Fiore R, Suleiman S, Drago-Ferrante R, Subbannayya Y, Pentimalli F, Giordano A, Calleja-Agius J. Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review. Int J Mol Sci 2022;23:5167. [PMID: 35563557 DOI: 10.3390/ijms23095167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Li X, Li X, Zhang B, He B, Papaccio G. The Role of Cancer Stem Cell-Derived Exosomes in Cancer Progression. Stem Cells International 2022;2022:1-13. [DOI: 10.1155/2022/9133658] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Wang X, Gao J, Li C, Xu C, Li X, Meng F, Liu Q, Wang Q, Yu L, Liu B, Li R. In situ gelatinase-responsive and thermosensitive nanocomplex for local therapy of gastric cancer with peritoneal metastasis. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100305] [Reference Citation Analysis]
31 Malla R, Puvalachetty K, Vempati RK, Marni R, Merchant N, Nagaraju GP. Cancer stem cells and circulatory tumor cells promote breast cancer metastasis. Clinical Breast Cancer 2022. [DOI: 10.1016/j.clbc.2022.05.004] [Reference Citation Analysis]
32 Adhikari S, Bhattacharya A, Adhikary S, Singh V, Gadad SS, Roy S, Das C. The paradigm of drug resistance in cancer: an epigenetic perspective. Biosci Rep 2022;42:BSR20211812. [PMID: 35438143 DOI: 10.1042/BSR20211812] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Harland N, Maurer FB, Abruzzese T, Bock C, Montes-Mojarro IA, Fend F, Aicher WK, Stenzl A, Amend B. Elevated Expression of the Immune Checkpoint Ligand CD276 (B7-H3) in Urothelial Carcinoma Cell Lines Correlates Negatively with the Cell Proliferation. Int J Mol Sci 2022;23:4969. [PMID: 35563359 DOI: 10.3390/ijms23094969] [Reference Citation Analysis]
34 Zhang Q, Li W. Correlation between amino acid metabolism and self-renewal of cancer stem cells: Perspectives in cancer therapy. World J Stem Cells 2022; 14(4): 267-286 [DOI: 10.4252/wjsc.v14.i4.267] [Reference Citation Analysis]
35 Bukhari SNA. Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials. Pharmaceutics 2022;14:866. [PMID: 35456698 DOI: 10.3390/pharmaceutics14040866] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Khan N, Ruchika, Kumar Dhritlahre R, Saneja A. Recent advances in dual-ligand targeted nanocarriers for cancer therapy. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.04.011] [Reference Citation Analysis]
37 Li J, Fang R, Wu J, Si Y, Bai J, Wang Q. The NOP14 nucleolar protein suppresses the function and stemness of melanoma stem-like cells through Wnt/beta-catenin signaling inactivation. Bioengineered 2022;13:7648-58. [DOI: 10.1080/21655979.2022.2050491] [Reference Citation Analysis]
38 Liu Y, Ao X, Yu W, Zhang Y, Wang J. Biogenesis, functions, and clinical implications of circular RNAs in non-small cell lung cancer. Mol Ther Nucleic Acids 2022;27:50-72. [PMID: 34938606 DOI: 10.1016/j.omtn.2021.11.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
39 An J, Peng C, Xie X, Peng F. New Advances in Targeted Therapy of HER2-Negative Breast Cancer. Front Oncol 2022;12:828438. [DOI: 10.3389/fonc.2022.828438] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Arjmand B, Hamidpour SK, Alavi-moghadam S, Yavari H, Shahbazbadr A, Tavirani MR, Gilany K, Larijani B. Molecular Docking as a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes. Front Pharmacol 2022;13:768556. [DOI: 10.3389/fphar.2022.768556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Aramini B, Masciale V, Grisendi G, Bertolini F, Maur M, Guaitoli G, Chrystel I, Morandi U, Stella F, Dominici M, Haider KH. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence. Cancers (Basel) 2022;14:976. [PMID: 35205721 DOI: 10.3390/cancers14040976] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
42 Yan R, Fan X, Xiao Z, Liu H, Huang X, Liu J, Zhang S, Yao J, An G, Ge Y. Inhibition of DCLK1 sensitizes resistant lung adenocarcinomas to EGFR-TKI through suppression of Wnt/β-Catenin activity and cancer stemness. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.01.030] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Singh P, Kumar Sahoo S. Piperlongumine loaded PLGA nanoparticles inhibit cancer stem-like cells through modulation of STAT3 in mammosphere model of triple negative breast cancer. Int J Pharm 2022;:121526. [PMID: 35104598 DOI: 10.1016/j.ijpharm.2022.121526] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
44 Filipa Cruz A, Fonseca NA, Rita Malheiro A, Melo JB, Manuela Gaspar M, Fernandes R, Moura V, Simões S, Nuno Moreira J. Targeted liposomal doxorubicin/ceramides combinations: the importance to assess the nature of drug interaction beyond bulk tumor cells. Eur J Pharm Biopharm 2022:S0939-6411(22)00012-1. [PMID: 35104605 DOI: 10.1016/j.ejpb.2022.01.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Yang Y, Meng WJ, Wang ZQ. Cancer Stem Cells and the Tumor Microenvironment in Gastric Cancer. Front Oncol 2021;11:803974. [PMID: 35047411 DOI: 10.3389/fonc.2021.803974] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
46 Tamai K, Fujimori H, Mochizuki M, Satoh K. Cancer Stem Cells in Intrahepatic Cholangiocarcinoma; Their Molecular Basis, and Therapeutic Implications. Front Physiol 2022;12:824261. [DOI: 10.3389/fphys.2021.824261] [Reference Citation Analysis]
47 Chen B, Sun H, Xu S, Mo Q. Long Non-coding RNA TPT1-AS1 Suppresses APC Transcription in a STAT1-Dependent Manner to Increase the Stemness of Colorectal Cancer Stem Cells. Mol Biotechnol 2022. [PMID: 35022996 DOI: 10.1007/s12033-022-00448-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Qin S, Xu Y, Li H, Chen H, Yuan Z. Recent advances in in situ oxygen-generating and oxygen-replenishing strategies for hypoxic-enhanced photodynamic therapy. Biomater Sci 2021;10:51-84. [PMID: 34882762 DOI: 10.1039/d1bm00317h] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
49 Liu S, Wen Y, Quan B, Lin J, Zhu Z, Tang J, Han S. [High expression of miR-3682-3p is an unfavorable prognostic factor of hepatocellular carcinoma]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:1885-91. [PMID: 35012923 DOI: 10.12122/j.issn.1673-4254.2021.12.19] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Wu R, Guo W, Qiu X, Wang S, Sui C, Lian Q, Wu J, Shan Y, Yang Z, Yang S, Wu T, Wang K, Zhu Y, Wang S, Liu C, Zhang Y, Zheng B, Li Z, Zhang Y, Shen S, Zhao Y, Wang W, Bao J, Hu J, Wu X, Jiang X, Wang H, Gu J, Chen L. Comprehensive analysis of spatial architecture in primary liver cancer. Sci Adv 2021;7:eabg3750. [PMID: 34919432 DOI: 10.1126/sciadv.abg3750] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
51 Zhou X, Xie X, Liu T, Chen S, Wang Y, Zhang J, Wang S, Wang Y, Dou S, Qi R, Kang N, Zhang D, Jin X, Cui R, Jiang H. REC8 enhances stemness and promotes metastasis of colorectal cancer through BTK/Akt/β-catenin signaling pathway. Transl Oncol 2022;15:101305. [PMID: 34890967 DOI: 10.1016/j.tranon.2021.101305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Jaramillo-rangel G, Chávez-briones M, Ancer-arellano A, Ortega-martínez M. Nestin-Expressing Cells in the Lung: The Bad and the Good Parts. Cells 2021;10:3413. [DOI: 10.3390/cells10123413] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
53 Meerson A, Khatib S, Mahajna J. Natural Products Targeting Cancer Stem Cells for Augmenting Cancer Therapeutics. Int J Mol Sci 2021;22:13044. [PMID: 34884848 DOI: 10.3390/ijms222313044] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
54 Troitskaya O, Novak D, Nushtaeva A, Savinkova M, Varlamov M, Ermakov M, Richter V, Koval O. EGFR Transgene Stimulates Spontaneous Formation of MCF7 Breast Cancer Cells Spheroids with Partly Loss of HER3 Receptor. Int J Mol Sci 2021;22:12937. [PMID: 34884742 DOI: 10.3390/ijms222312937] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Peng H, Wu X, Zhong R, Yu T, Cai X, Liu J, Wen Y, Ao Y, Chen J, Li Y, He M, Li C, Zheng H, Chen Y, Pan Z, He J, Liang W. Profiling Tumor Immune Microenvironment of Non-Small Cell Lung Cancer Using Multiplex Immunofluorescence. Front Immunol 2021;12:750046. [PMID: 34804034 DOI: 10.3389/fimmu.2021.750046] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
56 Acuña RA, Varas-Godoy M, Herrera-Sepulveda D, Retamal MA. Connexin46 Expression Enhances Cancer Stem Cell and Epithelial-to-Mesenchymal Transition Characteristics of Human Breast Cancer MCF-7 Cells. Int J Mol Sci 2021;22:12604. [PMID: 34830485 DOI: 10.3390/ijms222212604] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
57 Liu Z, Ren Y, Meng L, Li L, Beatson R, Deng J, Zhang T, Liu J, Han X. Epigenetic Signaling of Cancer Stem Cells During Inflammation. Front Cell Dev Biol 2021;9:772211. [PMID: 34722553 DOI: 10.3389/fcell.2021.772211] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
58 Yu W, Hu C, Gao H. Advances of nanomedicines in breast cancer metastasis treatment targeting different metastatic stages. Adv Drug Deliv Rev 2021;178:113909. [PMID: 34352354 DOI: 10.1016/j.addr.2021.113909] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
59 Chen J, Hou SF, Tang FJ, Liu DS, Chen ZZ, Zhang HL, Wang SH. HOTAIR/Sp1/miR-199a critically regulates cancer stemness and malignant progression of cutaneous squamous cell carcinoma. Oncogene 2021. [PMID: 34697449 DOI: 10.1038/s41388-021-02014-x] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
60 Xu A, Qian C, Lin J, Yu W, Jin J, Liu B, Tao H. Cell Differentiation Trajectory-Associated Molecular Classification of Osteosarcoma. Genes (Basel) 2021;12:1685. [PMID: 34828292 DOI: 10.3390/genes12111685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Li G, Gong J, Cao S, Wu Z, Cheng D, Zhu J, Huang X, Tang J, Yuan Y, Cai W, Zhang H. The Non-Coding RNAs Inducing Drug Resistance in Ovarian Cancer: A New Perspective for Understanding Drug Resistance. Front Oncol 2021;11:742149. [PMID: 34660304 DOI: 10.3389/fonc.2021.742149] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Thongchot S, Jamjuntra P, Prasopsiri J, Thuwajit P, Sawasdee N, Poungvarin N, Warnnissorn M, Sa-Nguanraksa D, O-Charoenrat P, Yenchitsomanus PT, Thuwajit C. Establishment and characterization of novel highly aggressive HER2‑positive and triple‑negative breast cancer cell lines. Oncol Rep 2021;46:254. [PMID: 34651665 DOI: 10.3892/or.2021.8205] [Reference Citation Analysis]
63 Zhang MJ, Wu CC, Wang S, Yang LL, Sun ZJ. Overexpression of LAG3, TIM3, and A2aR in adenoid cystic carcinoma and mucoepidermoid carcinoma. Oral Dis 2021. [PMID: 34651389 DOI: 10.1111/odi.14045] [Reference Citation Analysis]
64 Pan Y, Li K, Tao X, Zhao Y, Chen Q, Li N, Liu J, Go VLW, Guo J, Gao G, Xiao GG. MicroRNA-34a Alleviates Gemcitabine Resistance in Pancreatic Cancer by Repression of Cancer Stem Cell Renewal. Pancreas 2021;50:1260-6. [PMID: 34860809 DOI: 10.1097/MPA.0000000000001920] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
65 Yadollahi P, Jeon YK, Ng WL, Choi I. Current understanding of cancer-intrinsic PD-L1: regulation of expression and its protumoral activity. BMB Rep 2021;54:12-20. [PMID: 33298250 [PMID: 33298250 DOI: 10.5483/bmbrep.2021.54.1.241] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
66 Parsons RB, Facey PD. Nicotinamide N-Methyltransferase: An Emerging Protagonist in Cancer Macro(r)evolution. Biomolecules 2021;11:1418. [PMID: 34680055 DOI: 10.3390/biom11101418] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
67 Ding R, Li G, Yao Y, Zhang L, Zhang X, Li J, Shen T, Gao Y, Wu T, Kong S, Huang M, Li Y. Transgelin-2 interacts with CD44 to regulate Notch1 signaling pathway and participates in colorectal cancer proliferation and migration. J Physiol Biochem 2021. [PMID: 34553339 DOI: 10.1007/s13105-021-00843-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
68 Lin D, Chen X, Liu Y, Lin Z, Luo Y, Fu M, Yang N, Liu D, Cao J. Microgel Single-Cell Culture Arrays on a Microfluidic Chip for Selective Expansion and Recovery of Colorectal Cancer Stem Cells. Anal Chem 2021;93:12628-38. [PMID: 34495647 DOI: 10.1021/acs.analchem.1c02335] [Reference Citation Analysis]
69 Feng X, Cao A, Qin T, Zhang Q, Fan S, Wang B, Song B, Yu X, Li L. Abnormally elevated ubiquilin‑1 expression in breast cancer regulates metastasis and stemness via AKT signaling. Oncol Rep 2021;46:236. [PMID: 34528694 DOI: 10.3892/or.2021.8187] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Wan Kamarul Zaman WS, Nurul AA, Nordin F. Stem Cells and Cancer Stem Cells: The Jekyll and Hyde Scenario and Their Implications in Stem Cell Therapy. Biomedicines 2021;9:1245. [PMID: 34572431 DOI: 10.3390/biomedicines9091245] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
71 Yang Y, Wu J, Liu F, He J, Wu F, Chen J, Jiang Z. IGF2BP1 Promotes the Liver Cancer Stem Cell Phenotype by Regulating MGAT5 mRNA Stability by m6A RNA Methylation. Stem Cells Dev 2021;30:1115-25. [PMID: 34514861 DOI: 10.1089/scd.2021.0153] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
72 Guo Q, Yang C, Gao F. The state of CD44 activation in cancer progression and therapeutic targeting. FEBS J 2021. [PMID: 34478583 DOI: 10.1111/febs.16179] [Reference Citation Analysis]
73 Cao D, Naiyila X, Li J, Huang Y, Chen Z, Chen B, Li J, Guo J, Dong Q, Ai J, Yang L, Liu L, Wei Q. Potential Strategies to Improve the Effectiveness of Drug Therapy by Changing Factors Related to Tumor Microenvironment. Front Cell Dev Biol 2021;9:705280. [PMID: 34447750 DOI: 10.3389/fcell.2021.705280] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
74 Fan Q, Li L, Wang TL, Emerson RE, Xu Y. A Novel ZIP4-HDAC4-VEGFA Axis in High-Grade Serous Ovarian Cancer. Cancers (Basel) 2021;13:3821. [PMID: 34359722 DOI: 10.3390/cancers13153821] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
75 Qiao X, Zhang Y, Sun L, Ma Q, Yang J, Ai L, Xue J, Chen G, Zhang H, Ji C, Gu X, Lei H, Yang Y, Liu C. Association of human breast cancer CD44-/CD24- cells with delayed distant metastasis. Elife 2021;10:e65418. [PMID: 34318746 DOI: 10.7554/eLife.65418] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Arabzadeh A, Mortezazadeh T, Aryafar T, Gharepapagh E, Majdaeen M, Farhood B. Therapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: a mechanistic review. Cancer Cell Int 2021;21:391. [PMID: 34289841 DOI: 10.1186/s12935-021-02099-0] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
77 Tang W, Zhu S, Liang X, Liu C, Song L. The Crosstalk Between Long Non-Coding RNAs and Various Types of Death in Cancer Cells. Technol Cancer Res Treat 2021;20:15330338211033044. [PMID: 34278852 DOI: 10.1177/15330338211033044] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
78 Tagde P, Tagde P, Tagde S, Bhattacharya T, Garg V, Akter R, Rahman MH, Najda A, Albadrani GM, Sayed AA, Akhtar MF, Saleem A, Altyar AE, Kaushik D, Abdel-Daim MM. Natural bioactive molecules: An alternative approach to the treatment and control of glioblastoma multiforme. Biomed Pharmacother 2021;141:111928. [PMID: 34323701 DOI: 10.1016/j.biopha.2021.111928] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
79 Guo W, Wang H, Chen P, Shen X, Zhang B, Liu J, Peng H, Xiao X. Identification and Characterization of Multiple Myeloma Stem Cell-Like Cells. Cancers (Basel) 2021;13:3523. [PMID: 34298738 DOI: 10.3390/cancers13143523] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
80 Ji Z, Tian W, Gao W, Zang R, Wang H, Yang G. Cancer-Associated Fibroblast-Derived Interleukin-8 Promotes Ovarian Cancer Cell Stemness and Malignancy Through the Notch3-Mediated Signaling. Front Cell Dev Biol 2021;9:684505. [PMID: 34277625 DOI: 10.3389/fcell.2021.684505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
81 Chung KPS, Leung RWH, Lee TKW. Hampering Stromal Cells in the Tumor Microenvironment as a Therapeutic Strategy to Destem Cancer Stem Cells. Cancers (Basel) 2021;13:3191. [PMID: 34202411 DOI: 10.3390/cancers13133191] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Hong L, Zhou Y, Xie X, Wu W, Shi C, Lin H, Shi Z. A stemness-based eleven-gene signature correlates with the clinical outcome of hepatocellular carcinoma. BMC Cancer 2021;21:716. [PMID: 34147074 DOI: 10.1186/s12885-021-08351-0] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
83 Xelwa N, Candy GP, Devar J, Omoshoro-Jones J, Smith M, Nweke EE. Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance. Front Oncol 2021;11:683788. [PMID: 34195085 DOI: 10.3389/fonc.2021.683788] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
84 Oliveira BSA, de Assis ACC, Souza NM, Ferreira LFR, Soriano RN, Bilal M, Iqbal HMN. Nanotherapeutic approach to tackle chemotherapeutic resistance of cancer stem cells. Life Sci 2021;279:119667. [PMID: 34087280 DOI: 10.1016/j.lfs.2021.119667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
85 Zhang R, Liu P, Zhang X, Ye Y, Yu J. Lin28A promotes the proliferation and stemness of lung cancer cells via the activation of mitogen-activated protein kinase pathway dependent on microRNA let-7c. Ann Transl Med 2021;9:982. [PMID: 34277782 DOI: 10.21037/atm-21-2124] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
86 Ashrafizadeh M, Mohammadinejad R, Samarghandian S, Yaribeygi H, Johnston TP, Sahebkar A. Anti-Tumor Effects of Osthole on Different Malignant Tissues: A Review of Molecular Mechanisms. Anticancer Agents Med Chem 2020;20:918-31. [PMID: 32108003 DOI: 10.2174/1871520620666200228110704] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
87 She X, Gao Y, Zhao Y, Yin Y, Dong Z. A high-throughput screen identifies inhibitors of lung cancer stem cells. Biomed Pharmacother 2021;140:111748. [PMID: 34044271 DOI: 10.1016/j.biopha.2021.111748] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
88 Huang YJ, Lee TC, Pai YC, Lin BR, Turner JR, Yu LC. A novel tumor suppressor role of myosin light chain kinase splice variants through downregulation of the TEAD4/CD44 axis. Carcinogenesis 2021;42:961-74. [PMID: 34000008 DOI: 10.1093/carcin/bgab038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Sun G, Li Z, Rong D, Zhang H, Shi X, Yang W, Zheng W, Sun G, Wu F, Cao H, Tang W, Sun Y. Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges. Mol Ther Oncolytics 2021;21:183-206. [PMID: 34027052 DOI: 10.1016/j.omto.2021.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
90 Ashrafizadeh M, Zarrabi A, Orouei S, Zabolian A, Saleki H, Azami N, Bejandi AK, Mirzaei S, Janaghard MN, Hushmandi K, Nabavi N, Baradaran B, Kumar AP, Makvandi P, Samarghandian S, Khan H, Hamblin MR. Interplay between SOX9 transcription factor and microRNAs in cancer. Int J Biol Macromol 2021;183:681-94. [PMID: 33957202 DOI: 10.1016/j.ijbiomac.2021.04.185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
91 Li S, Wang H, Ma R, Wang L. Schisandrin B inhibits epithelial‑mesenchymal transition and stemness of large‑cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‑κB and p38 MAPK signaling pathways. Oncol Rep 2021;45:115. [PMID: 33907830 DOI: 10.3892/or.2021.8066] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
92 Gote V, Nookala AR, Bolla PK, Pal D. Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue. Int J Mol Sci 2021;22:4673. [PMID: 33925129 DOI: 10.3390/ijms22094673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
93 Ortíz R, Quiñonero F, García-Pinel B, Fuel M, Mesas C, Cabeza L, Melguizo C, Prados J. Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress. Cancers (Basel) 2021;13:2058. [PMID: 33923200 DOI: 10.3390/cancers13092058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
94 Li Y, Tang T, Lee HJ, Song K. Selective Anti-Cancer Effects of Plasma-Activated Medium and Its High Efficacy with Cisplatin on Hepatocellular Carcinoma with Cancer Stem Cell Characteristics. Int J Mol Sci 2021;22:3956. [PMID: 33921230 DOI: 10.3390/ijms22083956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
95 Chen Y, Zitello E, Guo R, Deng Y. The function of LncRNAs and their role in the prediction, diagnosis, and prognosis of lung cancer. Clin Transl Med 2021;11:e367. [PMID: 33931980 DOI: 10.1002/ctm2.367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
96 Zou X, Zhao Y, Liang X, Wang H, Zhu Y, Shao Q. Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape. Front Immunol 2021;12:641937. [PMID: 33868274 DOI: 10.3389/fimmu.2021.641937] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
97 Zhang H, Liu B, Cheng J, Ma H, Li Z, Xi Y. Identification of co-expressed genes associated with MLL rearrangement in pediatric acute lymphoblastic leukemia. Biosci Rep 2020;40:BSR20200514. [PMID: 32347296 DOI: 10.1042/BSR20200514] [Reference Citation Analysis]
98 Lei X, He Q, Li Z, Zou Q, Xu P, Yu H, Ding Y, Zhu W. Cancer stem cells in colorectal cancer and the association with chemotherapy resistance. Med Oncol 2021;38:43. [PMID: 33738588 DOI: 10.1007/s12032-021-01488-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
99 Pradhan A, Mishra S, Basu SM, Surolia A, Giri J, Srivastava R, Panda D. Targeted nanoformulation of C1 inhibits the growth of KB spheroids and cancer stem cell-enriched MCF-7 mammospheres. Colloids Surf B Biointerfaces 2021;202:111702. [PMID: 33780906 DOI: 10.1016/j.colsurfb.2021.111702] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Zając A, Król SK, Rutkowski P, Czarnecka AM. Biological Heterogeneity of Chondrosarcoma: From (Epi) Genetics through Stemness and Deregulated Signaling to Immunophenotype. Cancers (Basel) 2021;13:1317. [PMID: 33804155 DOI: 10.3390/cancers13061317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
101 Deng S, Wang J, Zhang L, Li J, Jin Y. LncRNA HOTAIR Promotes Cancer Stem-Like Cells Properties by Sponging miR-34a to Activate the JAK2/STAT3 Pathway in Pancreatic Ductal Adenocarcinoma. Onco Targets Ther 2021;14:1883-93. [PMID: 33737813 DOI: 10.2147/OTT.S286666] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
102 Su C, Zhang J, Yarden Y, Fu L. The key roles of cancer stem cell-derived extracellular vesicles. Signal Transduct Target Ther 2021;6:109. [PMID: 33678805 DOI: 10.1038/s41392-021-00499-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
103 Wang X, Bai Y, Yan X, Li J, Lin B, Dai L, Xu C, Li H, Li D, Yang T, Zhang T. Cucurbitacin B exhibits antitumor effects on CD133+ HepG2 liver cancer stem cells by inhibiting JAK2/STAT3 signaling pathway. Anticancer Drugs 2021;32:548-57. [PMID: 33675610 DOI: 10.1097/CAD.0000000000001062] [Reference Citation Analysis]
104 Li J, Ren H, Wang J, Zhang P, Shi X. Extracellular HMGB1 promotes CD44 expression in hepatocellular carcinoma via regulating miR-21. Aging (Albany NY) 2021;13:8380-95. [PMID: 33661757 DOI: 10.18632/aging.202649] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
105 Hervieu C, Christou N, Battu S, Mathonnet M. The Role of Cancer Stem Cells in Colorectal Cancer: From the Basics to Novel Clinical Trials. Cancers (Basel) 2021;13:1092. [PMID: 33806312 DOI: 10.3390/cancers13051092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
106 Xie J, Qi X, Wang Y, Yin X, Xu W, Han S, Cai Y, Han W. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway. Cell Oncol (Dordr) 2021;44:661-71. [PMID: 33651283 DOI: 10.1007/s13402-021-00592-2] [Reference Citation Analysis]
107 Lv L, Shi Y, Wu J, Li G. Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting. Int J Nanomedicine 2021;16:1487-508. [PMID: 33654398 DOI: 10.2147/IJN.S282110] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
108 Akil A, Gutiérrez-García AK, Guenter R, Rose JB, Beck AW, Chen H, Ren B. Notch Signaling in Vascular Endothelial Cells, Angiogenesis, and Tumor Progression: An Update and Prospective. Front Cell Dev Biol 2021;9:642352. [PMID: 33681228 DOI: 10.3389/fcell.2021.642352] [Cited by in Crossref: 5] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
109 Aramini B, Masciale V, Grisendi G, Banchelli F, D'Amico R, Maiorana A, Morandi U, Dominici M, Haider KH. Cancer stem cells and macrophages: molecular connections and future perspectives against cancer. Oncotarget 2021;12:230-50. [PMID: 33613850 DOI: 10.18632/oncotarget.27870] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
110 Praharaj PP, Patro BS, Bhutia SK. Dysregulation of mitophagy and mitochondrial homeostasis in cancer stem cells: Novel mechanism for anti-cancer stem cell-targeted cancer therapy. Br J Pharmacol 2021. [PMID: 33527371 DOI: 10.1111/bph.15401] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
111 Tao B, Song Y, Wu Y, Yang X, Peng T, Peng L, Xia K, Xia X, Chen L, Zhong C. Matrix stiffness promotes glioma cell stemness by activating BCL9L/Wnt/β-catenin signaling. Aging (Albany NY) 2021;13:5284-96. [PMID: 33535177 DOI: 10.18632/aging.202449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
112 Griñan-Lison C, Blaya-Cánovas JL, López-Tejada A, Ávalos-Moreno M, Navarro-Ocón A, Cara FE, González-González A, Lorente JA, Marchal JA, Granados-Principal S. Antioxidants for the Treatment of Breast Cancer: Are We There Yet? Antioxidants (Basel) 2021;10:205. [PMID: 33572626 DOI: 10.3390/antiox10020205] [Cited by in Crossref: 2] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
113 Low JL, Lau DP, Zhang X, Kwang XL, Rohatgi N, Chan JV, Chong FT, Wong SQR, Leong HS, Thangavelu MT, Rikka S, Skanderup AMJ, Tan DSW, Periyasamy G, Koh JLY, Iyer NG, DasGupta R. A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC). EBioMedicine 2021;64:103220. [PMID: 33529999 DOI: 10.1016/j.ebiom.2021.103220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
114 Pan G, Liu Y, Shang L, Zhou F, Yang S. EMT-associated microRNAs and their roles in cancer stemness and drug resistance. Cancer Commun (Lond) 2021;41:199-217. [PMID: 33506604 DOI: 10.1002/cac2.12138] [Cited by in Crossref: 7] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
115 Guo J, Guo M, Zheng J. Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway. Cancer Manag Res 2021;13:773-85. [PMID: 33536785 DOI: 10.2147/CMAR.S281969] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
116 Marzagalli M, Fontana F, Raimondi M, Limonta P. Cancer Stem Cells-Key Players in Tumor Relapse. Cancers (Basel) 2021;13:376. [PMID: 33498502 DOI: 10.3390/cancers13030376] [Cited by in Crossref: 3] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
117 Carvalho LS, Gonçalves N, Fonseca NA, Moreira JN. Cancer Stem Cells and Nucleolin as Drivers of Carcinogenesis. Pharmaceuticals (Basel) 2021;14:60. [PMID: 33451077 DOI: 10.3390/ph14010060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
118 Gu HF, Mao XY, Du M. Metabolism, absorption, and anti-cancer effects of sulforaphane: an update. Crit Rev Food Sci Nutr 2021;:1-17. [PMID: 33393366 DOI: 10.1080/10408398.2020.1865871] [Reference Citation Analysis]
119 Zheng X, Liu J, Liu Z, Wang J. Bio-inspired Ice-controlling Materials for Cryopreservation of Cells and Tissues. Acta Chimica Sinica 2021;79:729. [DOI: 10.6023/a21020043] [Reference Citation Analysis]
120 Qin Q, Yang B, Liu Z, Xu L, Song E, Song Y. Polychlorinated biphenyl quinone induced the acquisition of cancer stem cells properties and epithelial-mesenchymal transition through Wnt/β-catenin. Chemosphere 2021;263:128125. [PMID: 33297114 DOI: 10.1016/j.chemosphere.2020.128125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
121 Wang F, Luo R, Xin H, Zhang Y, Córdova Wong BJ, Wang W, Lei J. Hypoxia-stimulated tumor therapy associated with the inhibition of cancer cell stemness. Biomaterials 2020;263:120330. [DOI: 10.1016/j.biomaterials.2020.120330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
122 Kumar S, Behera A, Saha P, Kumar Srivastava A. The role of Krüppel-like factor 8 in cancer biology: Current research and its clinical relevance. Biochem Pharmacol 2021;183:114351. [PMID: 33253644 DOI: 10.1016/j.bcp.2020.114351] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
123 Zhang Y, Zhang R, Liang F, Zhang L, Liang X. Identification of Metabolism-Associated Prostate Cancer Subtypes and Construction of a Prognostic Risk Model. Front Oncol 2020;10:598801. [PMID: 33324566 DOI: 10.3389/fonc.2020.598801] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
124 Haldavnekar R, Vijayakumar SC, Venkatakrishnan K, Tan B. Prediction of Cancer Stem Cell Fate by Surface-Enhanced Raman Scattering Functionalized Nanoprobes. ACS Nano 2020;14:15468-91. [PMID: 33175514 DOI: 10.1021/acsnano.0c06104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
125 Fang W, Ni M, Zhang M, Chen H. Prognostic value of OCT4 in colorectal cancer: analysis using immunohistochemistry and bioinformatics validation. Biomark Med 2020;14:1473-84. [PMID: 33185466 DOI: 10.2217/bmm-2020-0069] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Praharaj PP, Panigrahi DP, Bhol CS, Patra S, Mishra SR, Mahapatra KK, Behera BP, Singh A, Patil S, Bhutia SK. Mitochondrial rewiring through mitophagy and mitochondrial biogenesis in cancer stem cells: A potential target for anti-CSC cancer therapy. Cancer Lett 2021;498:217-28. [PMID: 33186655 DOI: 10.1016/j.canlet.2020.10.036] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
127 Zhu G, Pan C, Bei JX, Li B, Liang C, Xu Y, Fu X. Mutant p53 in Cancer Progression and Targeted Therapies. Front Oncol 2020;10:595187. [PMID: 33240819 DOI: 10.3389/fonc.2020.595187] [Cited by in Crossref: 12] [Cited by in F6Publishing: 42] [Article Influence: 6.0] [Reference Citation Analysis]
128 Xie J, Yang P, Lin H, Li Y, Clementino M, Fenske W, Yang C, Wang C, Wang Z. Integrin α4 up-regulation activates the hedgehog pathway to promote arsenic and benzo[α]pyrene co-exposure-induced cancer stem cell-like property and tumorigenesis. Cancer Letters 2020;493:143-55. [DOI: 10.1016/j.canlet.2020.08.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
129 Chen J, Wang F, Lu Y, Yang S, Chen X, Huang Y, Lin X. CLC-3 and SOX2 regulate the cell cycle in DU145 cells. Oncol Lett 2020;20:372. [PMID: 33154770 DOI: 10.3892/ol.2020.12235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
130 Pritzker KPH. Colon Cancer Biomarkers: Implications for Personalized Medicine. J Pers Med. 2020;10. [PMID: 33066312 DOI: 10.3390/jpm10040167] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
131 Khan AQ, Rashid K, Alamodi AA, Raza SS, Uddin S. Recent developments in unraveling signaling mechanisms underlying drug resistance due to cancer stem-like cells. Current Opinion in Pharmacology 2020;54:130-41. [DOI: 10.1016/j.coph.2020.09.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
132 Juliano RL. Addressing cancer signal transduction pathways with antisense and siRNA oligonucleotides. NAR Cancer 2020;2:zcaa025. [PMID: 33015625 DOI: 10.1093/narcan/zcaa025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
133 van Lieshout L, van de Stolpe A, van der Ploeg P, Bowtell D, de Hullu J, Piek J. Signal Transduction Pathway Activity in High-Grade, Serous Ovarian Carcinoma Reveals a More Favorable Prognosis in Tumors with Low PI3K and High NF-κB Pathway Activity: A Novel Approach to a Long-Standing Enigma. Cancers (Basel) 2020;12:E2660. [PMID: 32961868 DOI: 10.3390/cancers12092660] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
134 Lee SH, Reed-newman T, Anant S, Ramasamy TS. Regulatory Role of Quiescence in the Biological Function of Cancer Stem Cells. Stem Cell Rev and Rep 2020;16:1185-207. [DOI: 10.1007/s12015-020-10031-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
135 Chen B, Ye P, Chen Y, Liu T, Cha JH, Yan X, Yang WH. Involvement of the Estrogen and Progesterone Axis in Cancer Stemness: Elucidating Molecular Mechanisms and Clinical Significance. Front Oncol 2020;10:1657. [PMID: 33014829 DOI: 10.3389/fonc.2020.01657] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
136 Li J, Jiang X, Li Z, Huang L, Ji D, Yu L, Zhou Y, Cui Y. SP1-induced HOXD-AS1 promotes malignant progression of cholangiocarcinoma by regulating miR-520c-3p/MYCN. Aging (Albany NY) 2020;12:16304-25. [PMID: 32857725 DOI: 10.18632/aging.103660] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
137 Fu J, Wu Z, Liu J, Wu T. Vitamin C: A stem cell promoter in cancer metastasis and immunotherapy. Biomed Pharmacother 2020;131:110588. [PMID: 32836076 DOI: 10.1016/j.biopha.2020.110588] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
138 Guan S, Wei J, Huang L, Wu L. Chemotherapy and chemo-resistance in nasopharyngeal carcinoma. Eur J Med Chem 2020;207:112758. [PMID: 32858472 DOI: 10.1016/j.ejmech.2020.112758] [Cited by in Crossref: 4] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
139 Fu F, Yang X, Zheng M, Zhao Q, Zhang K, Li Z, Zhang H, Zhang S. Role of Transmembrane 4 L Six Family 1 in the Development and Progression of Cancer. Front Mol Biosci 2020;7:202. [PMID: 33015133 DOI: 10.3389/fmolb.2020.00202] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
140 Lai X, Li Q, Wu F, Lin J, Chen J, Zheng H, Guo L. Epithelial-Mesenchymal Transition and Metabolic Switching in Cancer: Lessons From Somatic Cell Reprogramming. Front Cell Dev Biol 2020;8:760. [PMID: 32850862 DOI: 10.3389/fcell.2020.00760] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
141 Cersosimo F, Lonardi S, Bernardini G, Telfer B, Mandelli GE, Santucci A, Vermi W, Giurisato E. Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy. Int J Mol Sci 2020;21:E5207. [PMID: 32717819 DOI: 10.3390/ijms21155207] [Cited by in Crossref: 14] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
142 Soltanian S, Sheikhbahaei M, Ziasistani M. Phytol Down-Regulates Expression of Some Cancer Stem Cell Markers and Decreases Side Population Proportion in Human Embryonic Carcinoma NCCIT Cells. Nutr Cancer 2021;73:1520-33. [PMID: 32700607 DOI: 10.1080/01635581.2020.1795695] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
143 Ishikawa T, Terashima J, Sasaki D, Shimoyama Y, Yaegashi T, Sasaki M. Establishment and use of a three-dimensional ameloblastoma culture model to study the effects of butyric acid on the transcription of growth factors and laminin β3. Arch Oral Biol 2020;118:104845. [PMID: 32712305 DOI: 10.1016/j.archoralbio.2020.104845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
144 Olivares-Urbano MA, Griñán-Lisón C, Marchal JA, Núñez MI. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer. Cells 2020;9:E1651. [PMID: 32660072 DOI: 10.3390/cells9071651] [Cited by in Crossref: 12] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
145 Szatkowska M, Krupa R. Regulation of DNA Damage Response and Homologous Recombination Repair by microRNA in Human Cells Exposed to Ionizing Radiation. Cancers (Basel) 2020;12:E1838. [PMID: 32650508 DOI: 10.3390/cancers12071838] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
146 Cheng YQ, Wang SB, Liu JH, Jin L, Liu Y, Li CY, Su YR, Liu YR, Sang X, Wan Q, Liu C, Yang L, Wang ZC. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours. Cell Prolif 2020;53:e12865. [PMID: 32588948 DOI: 10.1111/cpr.12865] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
147 Lin M, Xiao Y, Jiang X, Zhang J, Guo T, Shi Y. A Combination Therapy of pHRE-Egr1-HSV-TK/Anti-CD133McAb- 131 I/MFH Mediated by FePt Nanoparticles for Liver Cancer Stem Cells. Journal of Nanomaterials 2020;2020:1-15. [DOI: 10.1155/2020/7180613] [Reference Citation Analysis]
148 Wang F, Zhang L, Liu J, Zhang J, Xu G. Highly expressed STAT1 contributes to the suppression of stemness properties in human paclitaxel-resistant ovarian cancer cells. Aging (Albany NY) 2020;12:11042-60. [PMID: 32516753 DOI: 10.18632/aging.103317] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
149 Wu S, Wang H, Pan Y, Yang X, Wu D. miR-140-3p enhances cisplatin sensitivity and attenuates stem cell-like properties through repressing Wnt/β-catenin signaling in lung adenocarcinoma cells. Exp Ther Med 2020;20:1664-74. [PMID: 32765679 DOI: 10.3892/etm.2020.8847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
150 Ashrafizadeh M, Zarrabi A, Hushmandi K, Kalantari M, Mohammadinejad R, Javaheri T, Sethi G. Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance. Int J Mol Sci 2020;21:E4002. [PMID: 32503307 DOI: 10.3390/ijms21114002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 81] [Article Influence: 19.0] [Reference Citation Analysis]
151 Safa AR. Resistance to drugs and cell death in cancer stem cells (CSCs). J Transl Sci 2020;6:341. [PMID: 35330670 DOI: 10.15761/jts.1000341] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
152 Ma Z, Zhang C, Liu X, Fang F, Liu S, Liao X, Tao S, Mai H. Characterisation of a subpopulation of CD133+ cancer stem cells from Chinese patients with oral squamous cell carcinoma. Sci Rep 2020;10:8875. [PMID: 32483269 DOI: 10.1038/s41598-020-64947-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
153 Zhao L, Lou G, Li A, Liu Y. lncRNA MALAT1 modulates cancer stem cell properties of liver cancer cells by regulating YAP1 expression via miR‑375 sponging. Mol Med Rep 2020;22:1449-57. [PMID: 32626943 DOI: 10.3892/mmr.2020.11196] [Cited by in Crossref: 8] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
154 Yuan L, Xu ZY, Ruan SM, Mo S, Qin JJ, Cheng XD. Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance. Mol Cancer. 2020;19:96. [PMID: 32460771 DOI: 10.1186/s12943-020-01219-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 99] [Article Influence: 13.5] [Reference Citation Analysis]
155 Huang W, Hu H, Zhang Q, Wang N, Yang X, Guo AY. Genome-Wide DNA Methylation Enhances Stemness in the Mechanical Selection of Tumor-Repopulating Cells. Front Bioeng Biotechnol 2020;8:88. [PMID: 32258002 DOI: 10.3389/fbioe.2020.00088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
156 Mortezaee K. CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis. Life Sci 2020;249:117534. [PMID: 32156548 DOI: 10.1016/j.lfs.2020.117534] [Cited by in Crossref: 39] [Cited by in F6Publishing: 61] [Article Influence: 19.5] [Reference Citation Analysis]
157 Huang X, Wu W, Yang W, Qing X, Shao Z. Surface engineering of nanoparticles with ligands for targeted delivery to osteosarcoma. Colloids Surf B Biointerfaces 2020;190:110891. [PMID: 32114271 DOI: 10.1016/j.colsurfb.2020.110891] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
158 Zheng W, Yao M, Wu M, Yang J, Yao D, Wang L. Secretory clusterin promotes hepatocellular carcinoma progression by facilitating cancer stem cell properties via AKT/GSK-3β/β-catenin axis. J Transl Med 2020;18:81. [PMID: 32059741 DOI: 10.1186/s12967-020-02262-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
159 Wang Y, Xu F, Chen Y, Tian Z. A quantitative N-glycoproteomics study of cell-surface N-glycoprotein markers of MCF-7/ADR cancer stem cells. Anal Bioanal Chem 2020;412:2423-32. [PMID: 32030495 DOI: 10.1007/s00216-020-02453-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
160 Bin Y, Ding Y, Xiao W, Liao A. RASSF1A: A promising target for the diagnosis and treatment of cancer. Clin Chim Acta 2020;504:98-108. [PMID: 31981586 DOI: 10.1016/j.cca.2020.01.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
161 Lai CY, Yeh DW, Lu CH, Liu YL, Chuang YC, Ruan JW, Kao CY, Huang LR, Chuang TH. Epigenetic Silencing of Ubiquitin Specific Protease 4 by Snail1 Contributes to Macrophage-Dependent Inflammation and Therapeutic Resistance in Lung Cancer. Cancers (Basel) 2020;12:E148. [PMID: 31936290 DOI: 10.3390/cancers12010148] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
162 Evangelisti C, Chiarini F, Cappellini A, Paganelli F, Fini M, Santi S, Martelli AM, Neri LM, Evangelisti C. Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia. J Cell Physiol 2020;235:5413-28. [PMID: 31904116 DOI: 10.1002/jcp.29429] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
163 Dal Monte M, Evans BA, Arioglu-Inan E, Michel MC. Upregulation of β3-adrenoceptors-a general marker of and protective mechanism against hypoxia? Naunyn Schmiedebergs Arch Pharmacol 2020;393:141-6. [PMID: 31853614 DOI: 10.1007/s00210-019-01780-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
164 Leng Z, Li Y, Zhou G, Lv X, Ai W, Li J, Hou L. Krüppel-like factor 4 regulates stemness and mesenchymal properties of colorectal cancer stem cells through the TGF-β1/Smad/snail pathway. J Cell Mol Med 2020;24:1866-77. [PMID: 31830379 DOI: 10.1111/jcmm.14882] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
165 Zhang C, Ma K, Li WY. Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway. Drug Des Devel Ther 2019;13:4075-90. [PMID: 31824138 DOI: 10.2147/DDDT.S224312] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
166 Najafi M, Farhood B, Mortezaee K, Kharazinejad E, Majidpoor J, Ahadi R. Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance. J Cancer Res Clin Oncol 2020;146:19-31. [PMID: 31734836 DOI: 10.1007/s00432-019-03080-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 57] [Article Influence: 14.3] [Reference Citation Analysis]
167 Paolillo M, Colombo R, Serra M, Belvisi L, Papetti A, Ciusani E, Comincini S, Schinelli S. Stem-Like Cancer Cells in a Dynamic 3D Culture System: A Model to Study Metastatic Cell Adhesion and Anti-Cancer Drugs. Cells 2019;8:E1434. [PMID: 31766310 DOI: 10.3390/cells8111434] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
168 Najafi M, Mortezaee K, Majidpoor J. Stromal reprogramming: A target for tumor therapy. Life Sci 2019;239:117049. [PMID: 31730862 DOI: 10.1016/j.lfs.2019.117049] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 8.7] [Reference Citation Analysis]
169 Carrà G, Cartellà A, Maffeo B, Morotti A. Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells. Blood Lymphat Cancer 2019;9:45-52. [PMID: 31807112 DOI: 10.2147/BLCTT.S228815] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
170 Jahanafrooz Z, Mosafer J, Akbari M, Hashemzaei M, Mokhtarzadeh A, Baradaran B. Colon cancer therapy by focusing on colon cancer stem cells and their tumor microenvironment. J Cell Physiol 2020;235:4153-66. [PMID: 31647128 DOI: 10.1002/jcp.29337] [Cited by in Crossref: 13] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
171 Sun HR, Wang S, Yan SC, Zhang Y, Nelson PJ, Jia HL, Qin L-X and Dong Q-Z. Therapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment. Front Oncol. 2019;9:1104. [PMID: 31709180 DOI: 10.3389/fonc.2019.01104] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
172 Hajizadeh F, Okoye I, Esmaily M, Ghasemi Chaleshtari M, Masjedi A, Azizi G, Irandoust M, Ghalamfarsa G, Jadidi-Niaragh F. Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells. Life Sci. 2019;237:116952. [PMID: 31622608 DOI: 10.1016/j.lfs.2019.116952] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
173 Brugnoli F, Grassilli S, Al-Qassab Y, Capitani S, Bertagnolo V. CD133 in Breast Cancer Cells: More than a Stem Cell Marker. J Oncol. 2019;2019:7512632. [PMID: 31636668 DOI: 10.1155/2019/7512632] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
174 Sverdlov ED, Chernov IP. Cancer Stem Complex, Not a Cancer Stem Cell, Is the Driver of Cancer Evolution. Biochemistry Moscow 2019;84:1028-39. [DOI: 10.1134/s0006297919090050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
175 Barbato L, Bocchetti M, Di Biase A, Regad T. Cancer Stem Cells and Targeting Strategies. Cells 2019;8:E926. [PMID: 31426611 DOI: 10.3390/cells8080926] [Cited by in Crossref: 28] [Cited by in F6Publishing: 53] [Article Influence: 9.3] [Reference Citation Analysis]
176 Schiavone K, Garnier D, Heymann MF, Heymann D. The Heterogeneity of Osteosarcoma: The Role Played by Cancer Stem Cells. Adv Exp Med Biol 2019;1139:187-200. [PMID: 31134502 DOI: 10.1007/978-3-030-14366-4_11] [Cited by in Crossref: 11] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
177 Kuo MC, Kuo PC, Mi Z. Myeloid zinc finger-1 regulates expression of cancer-associated fibroblast and cancer stemness profiles in breast cancer. Surgery 2019;166:515-23. [PMID: 31301870 DOI: 10.1016/j.surg.2019.05.042] [Reference Citation Analysis]
178 Calvete J, Larrinaga G, Errarte P, Martín AM, Dotor A, Esquinas C, Nunes-Xavier CE, Pulido R, López JI, Angulo JC. The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder. Hum Pathol 2019;91:61-8. [PMID: 31279874 DOI: 10.1016/j.humpath.2019.07.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
179 Vitale D, Kumar Katakam S, Greve B, Jang B, Oh ES, Alaniz L, Götte M. Proteoglycans and glycosaminoglycans as regulators of cancer stem cell function and therapeutic resistance. FEBS J 2019;286:2870-82. [PMID: 31230410 DOI: 10.1111/febs.14967] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 13.0] [Reference Citation Analysis]
180 Cordella M, Tabolacci C, Senatore C, Rossi S, Mueller S, Lintas C, Eramo A, D'Arcangelo D, Valitutti S, Facchiano A, Facchiano F. Theophylline induces differentiation and modulates cytoskeleton dynamics and cytokines secretion in human melanoma-initiating cells. Life Sci 2019;230:121-31. [PMID: 31125565 DOI: 10.1016/j.lfs.2019.05.050] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
181 Hu JL, Wang W, Lan XL, Zeng ZC, Liang YS, Yan YR, Song FY, Wang FF, Zhu XH, Liao WJ, Liao WT, Ding YQ, Liang L. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer. Mol Cancer. 2019;18:91. [PMID: 31064356 DOI: 10.1186/s12943-019-1019-x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 232] [Article Influence: 37.7] [Reference Citation Analysis]
182 Wang Y, Xu F, Xiao K, Chen Y, Tian Z. Site- and structure-specific characterization of N -glycoprotein markers of MCF-7 cancer stem cells using isotopic-labelling quantitative N -glycoproteomics. Chem Commun 2019;55:7934-7. [DOI: 10.1039/c9cc04114a] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
183 Ahmadi A, Najafi M, Farhood B, Mortezaee K. Transforming growth factor-β signaling: Tumorigenesis and targeting for cancer therapy. J Cell Physiol 2019;234:12173-87. [PMID: 30537043 DOI: 10.1002/jcp.27955] [Cited by in Crossref: 56] [Cited by in F6Publishing: 76] [Article Influence: 14.0] [Reference Citation Analysis]